Miki Takenaka Sato, Hideaki Yashima, Takuya Araki, Masashi Nomura, Kazuhiro Suzuki, Koujirou Yamamoto. Effect of dasatinib on blood concentrations of sunitinib and adverse events in a patient with metastatic renal cell carcinoma treated with sunitinib: A case report. Experimental and therapeutic medicine. 2025. 29. 4. 69-69
Ayumu Nagamine, Takuya Araki, Hideaki Yashima, Kiyohiro Oshima, Kyoko Obayashi, Koujirou Yamamoto. Patient resuscitated after cardiopulmonary arrest exhibits abnormally increased phenytoin metabolic rate due to unknown factors: a case report. Journal of pharmaceutical health care and sciences. 2024. 10. 1. 53-53
Yuya Higuchi, Yuya Ishikawa, Takuya Araki, Yukina Ohshima, Hideaki Yashima, Koujirou Yamamoto. Risk of Falls with Benzodiazepine Receptor Agonists in Combination with Novel hypnotics. Indonesian Journal of Pharmaceutics. 2024. 5. 2. 377-384
Masamitsu Takahashi, Takuya Araki, Hideaki Yashima, Ayumu Nagamine, Daisuke Nagano, Koujirou Yamamoto. Increased c-SRC expression is involved in acquired resistance to lenvatinib in hepatocellular carcinoma. Oncology letters. 2023. 26. 6. 529-529
西場弘美, 西場弘美, 長嶺歩, 八島秀明, 八島秀明, 高橋雄太, 樋口裕哉, 関崎直人, 中村浩規, 荒木拓也, et al. Evaluation of genetic factors in the interindividual variability of warfarin dosage in Japanese patients in adjusting for renal function. 日本薬学会年会要旨集(Web). 2024. 144th
Contamination of the Used Blister Packs by Lenalidomide in Clinical Situation.
(第27回日本医療薬学会年会 2017)
L-lactate dehydrogenase B (LDHB) is a possible predictive marker for sensitivity to anti-EGFR Mabs in colorectal cancer cell lines.
(15th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology (IATDMCT 2017) 2017)